Review



1419 fda approved drugs  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    TargetMol 1419 fda approved drugs
    a Schematic of iNap1 based high-throughput screening for compounds. b The effects of <t>1419</t> compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).
    1419 Fda Approved Drugs, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 138 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/1419 fda approved drugs/product/TargetMol
    Average 95 stars, based on 138 article reviews
    1419 fda approved drugs - by Bioz Stars, 2026-05
    95/100 stars

    Images

    1) Product Images from "Elevating cytosolic NADPH metabolism in endothelial cells ameliorates vascular aging"

    Article Title: Elevating cytosolic NADPH metabolism in endothelial cells ameliorates vascular aging

    Journal: Nature Communications

    doi: 10.1038/s41467-025-64652-z

    a Schematic of iNap1 based high-throughput screening for compounds. b The effects of 1419 compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).
    Figure Legend Snippet: a Schematic of iNap1 based high-throughput screening for compounds. b The effects of 1419 compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).

    Techniques Used: High Throughput Screening Assay, Fluorescence, Over Expression, Staining, Reverse Transcription Polymerase Chain Reaction



    Similar Products

    1419 fda approved drugs  (TargetMol)
    95
    TargetMol 1419 fda approved drugs
    a Schematic of iNap1 based high-throughput screening for compounds. b The effects of <t>1419</t> compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).
    1419 Fda Approved Drugs, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/1419 fda approved drugs/product/TargetMol
    Average 95 stars, based on 1 article reviews
    1419 fda approved drugs - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    fda-approved drug library  (TargetMol)
    95
    TargetMol fda-approved drug library
    a Schematic of iNap1 based high-throughput screening for compounds. b The effects of <t>1419</t> compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).
    Fda Approved Drug Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fda-approved drug library/product/TargetMol
    Average 95 stars, based on 1 article reviews
    fda-approved drug library - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    a Schematic of iNap1 based high-throughput screening for compounds. b The effects of 1419 compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).

    Journal: Nature Communications

    Article Title: Elevating cytosolic NADPH metabolism in endothelial cells ameliorates vascular aging

    doi: 10.1038/s41467-025-64652-z

    Figure Lengend Snippet: a Schematic of iNap1 based high-throughput screening for compounds. b The effects of 1419 compounds on iNap1 fluorescence ratio over iNapc fluorescence ratio. c The fluorescence ratio of cyto-iNap1 and cyto-iNapc with or without FA and shM1 overexpression in HAECs. n = 3 biologically independent samples, 101, 110, 111, 131, 112, 108, 120, and 117 cells for respective groups. Scale bar: 10 μm. d MTHFD1, p16, p21, and VCAM-1 protein levels in HAECs after shM1 overexpression. e p16, p21 and VCAM-1 protein levels with or without Ang II, FA and shM1 overexpression in HAECs. f Representative SA-β-Gal (upper) and EdU fluorescence (lower) staining images of HAECs with or without Ang II, FA and shM1 overexpression. Scale bar: 50 μm. Representative SA-β-Gal ( g ) and EdU fluorescence ( h ) staining images of old ECs with or without FA and shM1 overexpression. Scale bar: 50 μm. i p16, p21 and VCAM-1 protein levels in old ECs with or without FA and shM1 overexpression. j RT-PCR analysis of IL-1β, IL-6, IL-8 and CXCL1 mRNA levels in old ECs with or without FA and shM1 overexpression. n = 5 biologically independent samples. The fluorescence ratio of cyto-roGFP ( k ) and cyto-Hyper ( l ) with or without FA and shM1 overexpression in old ECs. n = 3 biologically independent samples, 122, 114, 117, 119, 117 and 118 cells for respective groups. Data are presented as mean values ± SEM. Statistical significance was assessed by One-way ANOVA followed by Tukey’s multiple comparisons test ( c , k , l ), Two-way ANOVA followed by Tukey’s multiple comparisons test ( j ).

    Article Snippet: 1419 FDA-approved drugs were purchased form TargetMol Chemicals Inc. and 100 μM drugs were directly added into HAECs.

    Techniques: High Throughput Screening Assay, Fluorescence, Over Expression, Staining, Reverse Transcription Polymerase Chain Reaction